These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 7861648)

  • 1. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
    Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
    Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
    Troncone L; Rufini V
    Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radioisotope therapy of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine--absorbed dose assessments using SPECT].
    Aritake S
    Kaku Igaku; 1992 Jun; 29(6):667-78. PubMed ID: 1640651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
    Nakabeppu Y; Nakajo M
    Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
    Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
    Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
    Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
    Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
    Pujol P; Bringer J; Faurous P; Jaffiol C
    Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effectiveness of iodine-131 MIBG metastases of a nonsecreting paraganglioma.
    Baulieu JL; Guilloteau D; Baulieu F; Le Floch O; Chambon C; Pourcelot L; Besnard JC
    J Nucl Med; 1988 Dec; 29(12):2008-13. PubMed ID: 3193214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
    Fitzgerald PA; Goldsby RE; Huberty JP; Price DC; Hawkins RA; Veatch JJ; Dela Cruz F; Jahan TM; Linker CA; Damon L; Matthay KK
    Ann N Y Acad Sci; 2006 Aug; 1073():465-90. PubMed ID: 17102115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
    Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic possibilities in metastatic pheochromocytoma].
    Vierhapper H; Raber W
    Zentralbl Chir; 1997; 122(6):494-7. PubMed ID: 9334119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.
    Koral KF; Wang XH; Sisson JC; Botti J; Meyer L; Mallette S; Glazer GM; Adler RS
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):211-8. PubMed ID: 2787315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.
    Khafagi FA; Shapiro B; Fischer M; Sisson JC; Hutchinson R; Beierwaltes WH
    Eur J Nucl Med; 1991; 18(3):191-8. PubMed ID: 1645665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
    Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
    J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
    Schvartz C; Gibold C; Vuillemin B; Delisle MJ
    J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.